Impact of admission anemia, C-reactive protein and mean platelet volume on short term mortality in patients with acute ST-elevation myocardial infarction treated with primary angioplasty

Clinical Biochemistry

Volumn 45, Issue 16-17, 2012, Pages 1506-1509

  Vrsalovic, Mislav ^a,b   Pintaric, Hrvoje ^b   Babic, Zdravko ^a,b   Pavlov, Marin ^c   Vrsalovic Presecki, Ana ^b   Getaldic, Biserka ^b   Vrkic, Nada ^b   Nikolic Heitzler, Vjeran ^a,b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Anemia; C reactive protein; Mean platelet volume; Mortality; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CLOPIDOGREL; CREATININE; EPTIFIBATIDE; HEMOGLOBIN; HEPARIN;

ADULT; AGED; ANEMIA; ANGIOPLASTY; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; CARDIAC PATIENT; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCORING SYSTEM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE VOLUME;

AGED; AGED, 80 AND OVER; ANEMIA; ANGIOPLASTY, BALLOON, CORONARY; BLOOD PLATELETS; C-REACTIVE PROTEIN; CELL SIZE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PROGNOSIS; RISK; ROC CURVE; SURVIVAL ANALYSIS;

EID: 84868303940     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.05.026     Document Type: Article

References (15)

1. Turner S.J., Ketch T.R., Gandhi S.K., Sane D.C. Routine hematologic clinical tests as prognostic markers in patients with acute coronary syndromes. Am Heart J 2008, 155:806-816. 10.1016/j.ahj.2007.11.037.
2. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
3. Chu S.G., Becker R.C., Berger P.B., Bhatt D.L., Eikelboom J.W., Konkle B., et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010, 8:148-156. 10.1111/j.1538-7836.2009.03584.x.
4. Nikolsky E., Aymong E.D., Halkin A., Grines C.L., Cox D.A., Garcia E., et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol 2004, 44:547-553. 10.1016/j.jacc.2004.03.080.
5. Scirica B.M., Morrow D.A., Cannon C.P., de Lemos J.A., Murphy S., Sabatine M.S., et al. Thrombolysis in Myocardial Infarction (TIMI) Study Group. Clinical application of C-reactive protein across the spectrum of acute coronary syndromes. Clin Chem 2007, 53:1800-1807. 10.1373/clinchem.2007.087957.
6. Addala S., Grines C.L., Dixon S.R., Stone G.W., Boura J.A., Ochoa A.B., et al. Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol 2004, 93:629-632. 10.1016/j.amjcard.2003.11.036.
7. Nikolic Heitzler V., Babic Z., Milicic D., Bergovec M., Raguz M., Mirat J., et al. Results of the Croatian primary percutaneous coronary intervention network for patients with ST-segment elevation acute myocardial infarction. Am J Cardiol 2010, 105:1261-1267. 10.1016/j.amjcard.2009.12.041.
8. Silber S., Albertsson P., Avilés F.F., Camici P.G., Colombo A., Hamm C., et al. Guidelines for percutaneous coronary interventions. Eur Heart J 2005, 26:804-847. Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. 10.1093/eurheartj/ehi138.
9. World Health Organization Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968, 405:5-37.
10. Ayhan E., Aycicek F., Uyarel H., Ergelen M., Cicek G., Gul M., et al. Patients with anemia on admission who have undergone primary angioplasty for ST elevation myocardial infarction: in-hospital and long-term clinical outcomes. Coron Artery Dis 2011, 22:375-379. 10.1097/MCA.0b013e3283472ac5.
11. Kurek T., Lenarczyk R., Kowalczyk J., Swiatkowski A., Kowalski O., Stabryła-Deska J., et al. Effect of anemia in high-risk groups of patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 2010, 105:611-618. 10.1016/j.amjcard.2009.10.036.
12. Meisinger C., Heier M., von Scheidt W., Kuch B. Admission C-reactive protein and short- as well as long-term mortality in diabetic versus non-diabetic patients with incident myocardial infarction. Clin Res Cardiol 2010, 99:817-823. MONICA/KORA Myocardial Infarction Registry. 10.1017/s00392-010-0193-z.
13. Kuch B., von Scheidt W., Kling B., Heier M., Hoermann A., Meisinger C. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases (MONICA)/Cooperative Health Research in the Region of Augsburg (KORA) Augsburg Myocardial Infarction Registry). Am J Cardiol 2008, 102:1125-1130. 10.1016/j.amjcard.2008.06.034.
14. Estévez-Loureiro R., Salgado-Fernández J., Marzoa-Rivas R., Barge-Caballero E., Pérez-Pérez A., Noriega-Concepción V., et al. Mean platelet volume predicts patency of the infarct-related artery before mechanical reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Thromb Res 2009, 124:536-540. 10.1016/j.thromres.2009.03.012.
15. Tekbas E., Kara A.F., Ariturk Z., Cil H., Islamoglu Y., Elbey M.A., et al. Mean platelet volume in predicting short- and long-term morbidity and mortality in patients with or without ST-segment elevation myocardial infarction. Scand J Clin Lab Invest 2011, 71:613-619. 10.3109/00365513.2011.599416.